Advertisement

J&J Suspends Sales of Power Morcellators Over Uterine Cancer Risk — Physician’s First Watch

Medical News |
May 1, 2014

J&J Suspends Sales of Power Morcellators Over Uterine Cancer Risk

By Amy Orciari Herman

Johnson & Johnson is halting sales of its power morcellators given concerns about the potential spread of undetected uterine cancer, the Wall Street Journal reports. The devices are used laparoscopically to cut uterine fibroids into smaller pieces for easier removal — a procedure that can spread undetected uterine sarcoma into the abdomen and pelvis, the FDA recently warned.

The company said the move affects all of its morcellators, sold under the names "Gynecare Morcellex," "Morcellex Sigma," and "Gynecare X-Tract." And although sales are being halted, products already sold aren't being recalled. Accordingly, doctors may continue using those in inventory.

The FDA is planning an advisory committee meeting to examine the safety and overall role of power morcellators in uterine surgery.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement